2024

Andrikopoulos, P. C., & Čabart, P. (2024). The chromatin remodeler SMARCA5 binds to d-block metal supports: Characterization of affinities by IMAC chromatography and QM analysis. PloS one, 19(10), e0309134. https://doi.org/10.1371/journal.pone.0309134 (IF 2.9. Q1) [PubMed]

Kaku Y, Okumura K, Padilla-Blanco M, Kosugi Y, Uriu K, Hinay AA Jr, Chen L, Plianchaisuk A, Kobiyama K, Ishii KJ; Genotype to Phenotype Japan (G2P-Japan) Consortium; Zahradnik J, Ito J, Sato K. Virological characteristics of the SARS-CoV-2 JN.1 variant. Lancet Infect Dis. 2024 Feb;24(2):e82. doi: 10.1016/S1473-3099(23)00813-7. (IF 36.4, D1) PubMed

Yajima, H., Anraku, Y., Kaku, Y., Kimura, K. T., Plianchaisuk, A., Okumura, K., Nakada-Nakura, Y., Atarashi, Y., Hemmi, T., Kuroda, D., Takahashi, Y., Kita, S., Sasaki, J., Sumita, H., Genotype to Phenotype Japan (G2P-Japan) Consortium, Ito, J., Maenaka, K., Sato, K., & Hashiguchi, T. (2024). Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1. Nature communications, 15(1), 8574. (IF 14.7, D1) PubMed

Yajima, H., Nomai, T., Okumura, K., Maenaka, K., Genotype to Phenotype Japan (G2P-Japan) Consortium, Ito, J., Hashiguchi, T., & Sato, K. (2024). Molecular and structural insights into SARS-CoV-2 evolution: from BA.2 to XBB subvariants. mBio, 15(10), e0322023. (IF 5.1, Q1) PubMed

Tamura T, Mizuma K, Nasser H, Deguchi S, Padilla-Blanco M, Oda Y, Uriu K, Tolentino JEM, Tsujino S, Suzuki R, Kojima I, Nao N, Shimizu R, Wang L, Tsuda M, Jonathan M, Kosugi Y, Guo Z, Hinay AA Jr, Putri O, Kim Y, Tanaka YL, Asakura H, Nagashima M, Sadamasu K, Yoshimura K; Genotype to Phenotype Japan (G2P-Japan) Consortium; Saito A, Ito J, Irie T, Tanaka S, Zahradnik J, Ikeda T, Takayama K, Matsuno K, Fukuhara T, Sato K. Virological characteristics of the SARS-CoV-2 BA.2.86 variant. Cell Host Microbe. 2024 Feb 14;32(2):170-180.e12. doi: 10.1016/j.chom.2024.01.001. (IF 20.6, D1) PubMed

Tsujino S, Deguchi S, Nomai T, Padilla-Blanco M, Plianchaisuk A, Wang L, Begum MM, Uriu K, Mizuma K, Nao N, Kojima I, Tsubo T, Li J, Matsumura Y, Nagao M, Oda Y, Tsuda M, Anraku Y, Kita S, Yajima H, Sasaki-Tabata K, Guo Z, Hinay AA Jr, Yoshimatsu K, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Nasser H, Jonathan M, Putri O, Kim Y, Chen L, Suzuki R, Tamura T, Maenaka K, Irie T, Matsuno K, Tanaka S, Ito J, Ikeda T, Takayama K, Zahradnik J, Hashiguchi T, Fukuhara T, Sato K; Genotype to Phenotype Japan (G2P‐Japan) Consortium. Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant. Microbiol Immunol. 2024 Sep;68(9):305-330. doi: 10.1111/1348-0421.13165. (IF 1.9, Q4) PubMed

Kuwata, T., Kaku, Y., Biswas, S., Matsumoto, K., Shimizu, M., Kawanami, Y., Uraki, R., Okazaki, K., Minami, R., Nagasaki, Y., Nagashima, M., Yoshida, I., Sadamasu, K., Yoshimura, K., Ito, M., Kiso, M., Yamayoshi, S., Imai, M., Ikeda, T., Sato, K., … Genotype to Phenotype Japan (G2P-Japan) Consortium (2024). Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection case. EBioMedicine, 110, 105439. (IF 9.7,D1) PubMed

Fujita, S., Plianchaisuk, A., Deguchi, S., Ito, H., Nao, N., Wang, L., Nasser, H., Tamura, T., Kimura, I., Kashima, Y., Suzuki, R., Suzuki, S., Kida, I., Tsuda, M., Oda, Y., Hashimoto, R., Watanabe, Y., Uriu, K., Yamasoba, D., Guo, Z., … Sato, K. (2024). Virological characteristics of a SARS-CoV-2-related bat coronavirus, BANAL-20-236. EBioMedicine, 104, 105181. (IF 9.7, D1) PubMed

2023

Kimura I, Yamasoba D, Nasser H, Ito H, Zahradnik J, Wu J, Fujita S, Uriu K, Sasaki J, Tamura T, Suzuki R, Deguchi S, Plianchaisuk A, Yoshimatsu K, Kazuma Y, Mitoma S, Schreiber G, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Takaori-Kondo A; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Shirakawa K, Takayama K, Irie T, Hashiguchi T, Nakagawa S, Fukuhara T, Saito A, Ikeda T, Sato K. Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics. J Virol. 2023 Oct 31;97(10):e0101123. doi: 10.1128/jvi.01011-23. (IF 5.4) [PubMed] 

Pham PN, Zahradník J, Kolářová L, Schneider B, Fuertes G. Regulation of IL-24/IL-20R2 complex formation using photocaged tyrosines and UV light. Front Mol Biosci. 2023 Jul 7;10:1214235. doi: 10.3389/fmolb.2023.1214235. (IF 5.0) [PubMed] 

Masuda Y, Nasser H, Zahradnik J, Mitoma S, Shimizu R, Nagata K, Takaori-Kondo A, Schreiber G, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Shirakawa K, Saito A, Ikeda T, Ito J and Sato K (2023) Characterization of the evolutionary and virological aspects of mutations in the receptor binding motif of the SARS-CoV-2 spike protein. Front. Virol. 3:1328229. doi: 10.3389/fviro.2023.1328229. (IF N/A)

Yamasoba D, Uriu K, Plianchaisuk A, Kosugi Y, Pan L, Zahradnik J; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Sato K. Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant. Lancet Infect Dis. 2023 Jun;23(6):655-656. doi: 10.1016/S1473-3099(23)00278-5. Epub 2023 May 3. (IF 56.3) [PubMed]

Tamura T, Ito J, Uriu K, Zahradnik J, Kida I, Anraku Y, Nasser H, Shofa M, Oda Y, Lytras S, Nao N, Itakura Y, Deguchi S, Suzuki R, Wang L, Begum MM, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Shimizu R, Tsuda M, Kosugi Y, Fujita S, Pan L, Sauter D, Yoshimatsu K, Suzuki S, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Yamamoto Y, Nagamoto T, Schreiber G, Maenaka K; Genotype to Phenotype Japan (G2P-Japan) Consortium; Hashiguchi T, Ikeda T, Fukuhara T, Saito A, Tanaka S, Matsuno K, Takayama K, Sato K. Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants. Nat Commun. 2023 May 16;14(1):2800. doi: 10.1038/s41467-023-38435-3. (IF 16.6) [PubMed]

Ito J, Suzuki R, Uriu K, Itakura Y, Zahradnik J, Kimura KT, Deguchi S, Wang L, Lytras S, Tamura T, Kida I, Nasser H, Shofa M, Begum MM, Tsuda M, Oda Y, Suzuki T, Sasaki J, Sasaki-Tabata K, Fujita S, Yoshimatsu K, Ito H, Nao N, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Yamamoto Y, Nagamoto T, Kuramochi J, Schreiber G; Genotype to Phenotype Japan (G2P-Japan) Consortium; Saito A, Matsuno K, Takayama K, Hashiguchi T, Tanaka S, Fukuhara T, Ikeda T, Sato K. Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant. Nat Commun. 2023 May 11;14(1):2671. doi: 10.1038/s41467-023-38188-z. (IF 16.6) [PubMed]

Uriu K, Ito J, Zahradnik J, Fujita S, Kosugi Y, Schreiber G; Genotype to Phenotype Japan (G2P-Japan) Consortium; Sato K. Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant. Lancet Infect Dis. 2023 Mar;23(3):280-281. doi: 10.1016/S1473-3099(23)00051-8. (IF 56.3) [PubMed]

2022

Saito A, Tamura T, Zahradnik J, Deguchi S, Tabata K, Anraku Y, Kimura I, Ito J, Yamasoba D, Nasser H, Toyoda M, Nagata K, Uriu K, Kosugi Y, Fujita S, Shofa M, Monira Begum M, Shimizu R, Oda Y, Suzuki R, Ito H, Nao N, Wang L, Tsuda M, Yoshimatsu K, Kuramochi J, Kita S, Sasaki-Tabata K, Fukuhara H, Maenaka K, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Ueno T, Schreiber G, Takaori-Kondo A; Genotype to Phenotype Japan (G2P-Japan) Consortium; Shirakawa K, Sawa H, Irie T, Hashiguchi T, Takayama K, Matsuno K, Tanaka S, Ikeda T, Fukuhara T, Sato K. Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant. Cell Host Microbe. 2022 Nov 9;30(11):1540-1555.e15. doi: 10.1016/j.chom.2022.10.003. (IF 31.37) [PubMed]